The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gender representation in authorship in later-phase systemic clinical trials in biliary tract cancer (BTC).
 
Mairead Geraldine McNamara
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Shire; Sirtex Medical
Speakers' Bureau - Nucana
Research Funding - Ipsen; Nucana; SERVIER
Travel, Accommodations, Expenses - Bayer; Novartis
 
John A. Bridgewater
Honoraria - Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Merck Serono; Roche; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene
Research Funding - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER
 
Lipika Goyal
Consulting or Advisory Role - Agios; Alentis Therapeutics; AstraZeneca; Debiopharm Group; H3 Biomedicine; Incyte; Klus Pharma; QED Therapeutics; Sirtex Medical; Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Agios; Debiopharm Group; Taiho Pharmaceutical
 
David Goldstein
No Relationships to Disclose
 
Rachna T. Shroff
Consulting or Advisory Role - Agios; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Debiopharm Group; Exelixis; Incyte; Merck; QED Therapeutics; Seagen; Taiho Pharmaceutical
Research Funding - Agios; Exelixis; Halozyme; Merck; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Taiho Pharmaceutical
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Servier; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; SERVIER; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; ESMO; German Cancer Society; Merck Serono; MSD; Roche
 
Maeve Aine Lowery
Consulting or Advisory Role - Agios; Roche/Genentech
Travel, Accommodations, Expenses - Ipsen
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Bayer (Inst); Celgene (Inst); Immuneering; Imugene; Incyte (Inst); Ipsen (Inst); Lilly (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - ARMO BioSciences; AstraZeneca; Exelixis; Lilly; Merck (Inst); Sillajen
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exact Sciences; Genentech/Roche; Gilead Sciences; Merck (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Partner Therapeutics (Inst); QED Therapeutics (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Junji Furuse
Honoraria - Abbvie; Astellas Pharma; AstraZeneca; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; EA Pharma; Eisai; Fujifilm; Kyowa Hakko Kirin; Lilly Japan; Merck; Mochida Pharmaceutical Co. Ltd.; MSD; Mylan; Nihon Servier; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Shionogi; Shire; Taiho Pharmaceutical; Takeda; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Chugai Pharma; Eisai; Fujifilm; J-Pharma; Lilly Japan; Merck; MSD; Mundipharma; Novartis; OncoTherapy Science; Ono Pharmaceutical; Otsuka; Shire; Sumitomo Dainippon; Taiho Pharmaceutical; Takara Bio; Yakult Honsha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); J-Pharma (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; Eisai; Gilead Sciences; Incyte; Ipsen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Amgen; ArQule; AstraZeneca; Basilea; Baxter; Bayer; Celgene; Eisai; Exelixis; Hengrui Therapeutics; Incyte; Ipsen; Italfarmaco; Lilly; Merck Sharp & Dohme; Nerviano Medical Sciences; Roche; Sanofi; Sirtex Medical
Research Funding - Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); FibroGen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Roche
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Chigusa Morizane
Honoraria - Eisai; Merck Sharp & Dohme; Novartis; Taiho Pharmaceutical; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - Abbvie; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Taiho Pharmaceutical; Yakult Honsha
Research Funding - AstraZeneca (Inst); Eisai (Inst); J-Pharma (Inst); Merck (Inst); ONO PHARMACEUTICAL (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Angela Lamarca
Consulting or Advisory Role - Eisai; Ipsen; Nutricia; Nutricia (I); QED Therapeutics; Roche
Speakers' Bureau - Advanced Accelerator Applications; Incyte; Ipsen; Ipsen (I); Merck; Novartis (I); Pfizer; Pfizer (I)
Research Funding - Ipsen; Ipsen (I)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Bayer; Celgene; Delcath Systems; Ipsen; Ipsen (I); Mylan; NanoString Technologies (I); Novartis; Pfizer; Sirtex Medical
 
Richard Hubner
Honoraria - Abbott Nutrition; Ipsen
Consulting or Advisory Role - BTG; Eisai; Shire
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Jennifer J. Knox
Honoraria - Novartis; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; AstraZeneca; Debiopharm Group; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Wren Laboratories
Speakers' Bureau - Imaging Equipment Limited; Ipsen; Novartis; Nucana
Travel, Accommodations, Expenses - Lilly; Nucana; Pfizer